Web Analytics

3 Latest Announced Rounds

$1,738.89M Raised in 75 Funding Rounds in the past 7 Days - View All

Funding Round Profile

AATec Medical

start up
Germany - Munich Area
  • 18/07/2023
  • Seed
  • $3,033,000

AATec Medical GmbH is a biotech company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, virus infections and rare diseases. The first product candidate is a novel AAT formulation for inhalation to treat emerging inflammatory diseases of the lung and respiratory virus infections.

Related People

Ruediger JankowskyCo Founder

Ruediger Jankowsky Germany - Munich, Bavaria

Senior executive in the biopharmaceutical industry with 20+ years of experience in product development and business development. Passionate about transforming innovation in life sciences into products that make a significant difference to patients.

Track record of successful drug development and commercial licensing of biopharmaceuticals and biosimilars for oncology, autoimmune diseases and rare diseases. In-depth expertise in the development and market launch of digital health products as medical devices. Leader of various international cross-functional teams for R&D, regulatory, business development/licensing, and early launch phases in both, mid-size and corporate environments. Built several start-up companies in the biopharmaceutical and MedTech space.